{"database": "openregs", "table": "documents", "rows": [["FDA-2017-D-0085-0022", "FDA", "FDA-2017-D-0085", "Reference-21-FDA-2014-Guidance-Public-Availability-Advisory-Committee-Members-Financial-Interest-Information-Waivers re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance", "Supporting & Related Material", "Background Material", "2017-11-27T05:00:00Z", 2017, 11, null, null, "2017-11-27T21:57:54Z", null, 0, 0, "0900006482cb21a9"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-D-0085-0022"], "units": {}, "query_ms": 2.108076005242765, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}